4.8 Article

Mental disorders and risk of suicide attempt: a national prospective study

Journal

MOLECULAR PSYCHIATRY
Volume 20, Issue 6, Pages 718-726

Publisher

SPRINGERNATURE
DOI: 10.1038/mp.2015.19

Keywords

-

Funding

  1. NIH [DA019606, MH076051, MH082773]
  2. New York State Psychiatric Institute, NIDA [1F32DA036431]
  3. Public Health Expertise

Ask authors/readers for more resources

Most mental disorders, when examined independently, are associated with an elevated risk for suicide attempt. However, mental disorders often co-occur, and that co-occurrence is well explained by models where specific mental disorders are understood as manifestations of latent dimensions of psychopathology. To date, it remains unclear whether the risk of suicide attempt is due to specific mental disorders, to specific dimensions of psychopathology (that is, internalizing and externalizing dimensions), to a general psychopathology factor or to a combination of these explanations. In a large nationally representative prospective survey, the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), we used structural equation modeling to examine the shared and specific effects of Axis I and Axis II disorders on the occurrence of suicide attempts in the general population and among individuals with a lifetime history of suicidal ideation. Effects of mental disorders on the risk of suicide attempt were exerted almost exclusively through a general psychopathology factor representing the shared effect across all mental disorders. Effects of remitted psychiatric disorders on the risk of suicide attempt were fully mediated by current mental disorders. Similar patterns of associations were found in individuals with suicidal ideation. These results held when using different approaches to modeling psychiatric comorbidity. Our findings underscore the importance of adopting dimensional approaches to comorbidity in the study of suicidal behavior. Because mental disorders increase the risk of suicide attempt through a general psychopathology liability, this dimension should be considered as an important therapeutic target to substantially advance suicide prevention.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Psychiatry

Is a Diagnosis of Schizophrenia Spectrum Disorder Associated With Increased Mortality in Patients With COVID-19?

Marina Sanchez-Rico, Frederic Limosin, Nicolas Hoertel

AMERICAN JOURNAL OF PSYCHIATRY (2022)

Article Psychology, Clinical

Toward a generalized developmental model of psychopathological liabilities and psychiatric disorders

Carlos Blanco, Melanie M. Wall, Nicolas Hoertel, Robert F. Krueger, Mark Olfson

Summary: Most risk factors for psychiatric disorders are mediated through broad psychopathological dimensions, supporting the need for a trans-diagnostic approach to etiological research and intervention.

PSYCHOLOGICAL MEDICINE (2023)

Article Clinical Neurology

Psychiatric symptoms and mortality in older adults with major psychiatric disorders: results from a multicenter study

Margaux Chene, Marina Sanchez-Rico, Carlos Blanco, Rachel Pascal De Raykeer, Cecile Hanon, Pierre Vandel, Frederic Limosin, Nicolas Hoertel

Summary: In older adults with major psychiatric disorders, all psychiatric symptoms are associated with increased mortality, mainly through a general psychopathology dimension. No BPRS item or lower order factor has a significant effect on mortality beyond the general psychopathology factor. Greater number of medical conditions, older age, male sex, and being hospitalized or institutionalized at baseline are significantly associated with this increased risk, independently from the general psychopathology factor.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2023)

Article Immunology

Prevalence of Medical Contraindications to Nirmatrelvir/Ritonavir in a Cohort of Hospitalized and Nonhospitalized Patients With COVID-19

Sarah Lim, Christopher J. Tignanelli, Nicolas Hoertel, David R. Boulware, Michael G. Usher

Summary: This analysis examines the prevalence of contraindications to nirmatrelvir/ritonavir among 66,007 COVID-19 patients. Possible contraindications were found in 14.8% of patients, and the prevalence increased with higher severity of illness.

OPEN FORUM INFECTIOUS DISEASES (2022)

Article Oncology

Benefits of Homeopathic Complementary Treatment in Patients With Breast Cancer: A Retrospective Cohort Study Based on the French Nationwide Healthcare Database

Jacques Medioni, Daniel Scimeca, Yecenia Lopez Marquez, Emmanuelle Leray, Marie Dalichampt, Nicolas Hoertel, Mohammed Bennani, Pascal Trempat, Naoual Boujedaini

Summary: This study evaluated the benefits of homeopathy on the quality of life of patients with nonmetastatic breast cancer. The use of homeopathy in patients with breast cancer after diagnosis has increased, leading to a decrease in medications for palliating cancer treatment side effects. This indicates an improvement in quality of life for patients who use homeopathy.

CLINICAL BREAST CANCER (2023)

Article Psychiatry

Using filled prescription sequences to rank antidepressants: A nationwide replication study

Charles Ouazana-Vedrines, Thomas Lesuffleur, Pierre Denis, Nicolas Hoertel, Frederic Limosin, Antoine Rachas, Philippe Tuppin, Cedric Lemogne

Summary: Ranking antidepressants based on efficacy and tolerability in the general population helps in selecting the best first-line medication. This study aimed to replicate a proof-of-concept study by ranking antidepressants based on prescription sequences consistent with continuation or change. Using a nationwide cohort from the French national health data system, the study provides evidence that prescription sequences are a reliable and reproducible tool for ranking antidepressant treatments in real life settings. The results showed that escitalopram was the most acceptable option, followed by venlafaxine, citalopram, sertraline, fluoxetine, and paroxetine.

JOURNAL OF PSYCHIATRIC RESEARCH (2023)

Article Psychiatry

Approximating defense mechanisms in a national study of adults: prevalence and correlates with functioning

Carlos Blanco, Leonie Kampe, Melanie M. Wall, Shang-Min Liu, Shuai Wang, Eve Caligor, Mark Olfson

Summary: Despite the lack of published studies on the prevalence and correlates of defense mechanisms in nationally representative samples, this study used approximations from personality traits assessments to estimate the prevalence and correlates of 12 defense mechanisms in a representative sample of US adults. The results showed that neurotic, immature, and pathological defense mechanisms are prevalent in the general population and associated with psychosocial impairment. Recognizing defense mechanisms may be important in clinical practice regardless of treatment modality.

TRANSLATIONAL PSYCHIATRY (2023)

Article Geriatrics & Gerontology

Impact of lithium on mortality among older adults with major psychiatric disorders: A 5-year prospective multicenter study

Emmanuel Leleu, Marina Sanchez-Rico, Miriam Abellan, Carlos Blanco, Sunthavy Yeim, Esther Chaugne, Frederic Limosin, Nicolas Hoertel

Summary: This study examines the association between lithium use and all-cause mortality and specific causes of death among older adults with psychiatric disorders. The results show that lithium use is not significantly associated with all-cause or disease-related mortality, and may be associated with a reduced risk of suicide.

AGING & MENTAL HEALTH (2023)

Article Psychiatry

Trust in sources of information on COVID-19 at the beginning of the pandemic?s first wave and incident persistent symptoms in the population-based CONSTANCES cohort: A prospective study*

Joane Matta, Emmanuel Wiernik, Olivier Robineau, Gianluca Severi, Mathilde Touvier, Clement Gouraud, Charles Ouazana-Vedrines, Victor Pitron, Brigitte Ranque, Nicolas Hoertel, Omer Van den Bergh, Michael Witthoeft, Sofiane Kab, Marcel Goldberg, Marie Zins, Cedric Lemogne

Summary: This study aimed to investigate the association between trust in different sources of information on COVID-19 at the beginning of the pandemic and the burden of incident persistent symptoms. Using data from the French CONSTANCES population-based cohort, the study found that participants with higher trust in government/journalists had fewer incident persistent symptoms at follow-up. Trust in government/journalists and medical doctors/scientists was also associated with a lower likelihood of having at least one symptom.

JOURNAL OF PSYCHOSOMATIC RESEARCH (2023)

Article Psychology, Developmental

Prevalence and Correlates of Mental Disorders in Children Aged 9 and 10 Years: Results From the ABCD Study

Mark Olfson, Melanie M. Wall, Shuai Wang, Carlos Blanco

Summary: The objective of this study was to estimate the prevalence of current DSM-5 disorders in children aged 9 to 10 and their associations with sociodemographic and physical characteristics. The study found that the prevalence of any current mental disorder was 10.11%, with higher rates among boys and children from low-income families. Boys, children from families with incomes below $25,000 and $25,000 to $49,000, and obese children were at increased risk for any current child mental disorder. Children from low-income families were particularly at risk for attention-deficit/hyperactivity disorder and disruptive behavior disorders.

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2023)

Article Biochemistry & Molecular Biology

Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19 in Uganda: a prospective interventional open-label cohort study

Bruce J. Kirenga, Levicatus Mugenyi, Marina Sanchez-Rico, Henry Kyobe, Winters Muttamba, Raymond Mugume, Eliya Mwesigwa, Ezra Kalimo, Vicky Nyombi, Ivan Segawa, Loryndah Olive Namakula, Rogers Sekibira, Wilberforce Kabweru, Rosemary Byanyima, Hellen Aanyu, Pauline Byakika-Kibwika, Henry G. Mwebesa, Nicolas Hoertel, William Bazeyo

Summary: Prior research suggests that fluvoxamine, an SSRI used for mental disorders, may be effective against COVID-19. This study found that fluvoxamine was associated with reduced mortality and increased symptom resolution in inpatients with COVID-19. However, further research is needed to confirm these findings and assess potential side effects.

MOLECULAR PSYCHIATRY (2023)

Article Psychiatry

Associations Between Early Life Adversity, Reproduction-Oriented Life Strategy, and Borderline Personality Disorder

Axel Baptista, Valerian Chambon, Nicolas Hoertel, Mark Olfson, Carlos Blanco, David Cohen, Pierre O. Jacquet

Summary: This study found that the emergence of borderline personality disorder (BPD) is associated with prioritizing short-term reproductive goals over long-term somatic maintenance goals, which can be seen as a developmental response to adverse early life experiences. Early life adversity is directly or indirectly associated with a diagnosis of BPD, and prioritizing short-term reproductive goals further increases the risk of BPD. These findings help explain the physiological and behavioral correlates of BPD.

JAMA PSYCHIATRY (2023)

Article Chemistry, Medicinal

Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational Study

Nicolas Hoertel, Katayoun Rezaei, Marina Sanchez-Rico, Alfonso Delgado-Alvarez, Johannes Kornhuber, Erich Gulbins, Mark Olfson, Charles Ouazana-Vedrines, Alexander Carpinteiro, Celine Cougoule, Katrin Anne Becker, Jesus M. Alvarado, Frederic Limosin

Summary: The study suggests that the use of medications inhibiting acid sphingomyelinase (FIASMA) can reduce the risk of mortality in patients with SARS-CoV-2 infection. The multicenter retrospective observational study included 72,105 adult patients and found a significant association between FIASMA medication use and reduced 28-day mortality risk.

PHARMACEUTICALS (2023)

Article Psychiatry

Comorbidity patterns and mortality among hospitalized patients with psychiatric disorders and COVID-19

Marina Sanchez-Rico, Katayoun Rezaei, Alfonso Delgado-Alvarez, Frederic Limosin, Nicolas Hoertel, Jesus M. Alvarado

Summary: Psychiatric and non-psychiatric comorbidity may be associated with increased 28-day mortality among patients with psychiatric disorders and COVID-19, with the exception of a lower risk of death observed in patients with mood disorders.

BRAZILIAN JOURNAL OF PSYCHIATRY (2023)

No Data Available